134 related articles for article (PubMed ID: 26352738)
1. Inhibition of LtxA toxicity by blocking cholesterol binding with peptides.
Brown AC; Koufos E; Balashova NV; Boesze-Battaglia K; Lally ET
Mol Oral Microbiol; 2016 Feb; 31(1):94-105. PubMed ID: 26352738
[TBL] [Abstract][Full Text] [Related]
2. Aggregatibacter actinomycetemcomitans leukotoxin utilizes a cholesterol recognition/amino acid consensus site for membrane association.
Brown AC; Balashova NV; Epand RM; Epand RF; Bragin A; Kachlany SC; Walters MJ; Du Y; Boesze-Battaglia K; Lally ET
J Biol Chem; 2013 Aug; 288(32):23607-21. PubMed ID: 23792963
[TBL] [Abstract][Full Text] [Related]
3. Membrane localization of the Repeats-in-Toxin (RTX) Leukotoxin (LtxA) produced by Aggregatibacter actinomycetemcomitans.
Brown AC; Boesze-Battaglia K; Balashova NV; Mas Gómez N; Speicher K; Tang HY; Duszyk ME; Lally ET
PLoS One; 2018; 13(10):e0205871. PubMed ID: 30335797
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Bacterial Toxin Activity by the Nuclear Stain, DRAQ5™.
Webb JN; Koufos E; Brown AC
J Membr Biol; 2016 Aug; 249(4):503-11. PubMed ID: 27039399
[TBL] [Abstract][Full Text] [Related]
5.
Nice JB; Balashova NV; Kachlany SC; Koufos E; Krueger E; Lally ET; Brown AC
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322160
[TBL] [Abstract][Full Text] [Related]
6. Receptor-Based Peptides for Inhibition of Leukotoxin Activity.
Krueger E; Hayes S; Chang EH; Yutuc S; Brown AC
ACS Infect Dis; 2018 Jul; 4(7):1073-1081. PubMed ID: 29742342
[TBL] [Abstract][Full Text] [Related]
7. Aggregatibacter actinomycetemcomitans leukotoxin causes activation of lymphocyte function-associated antigen 1.
Nygren P; Balashova N; Brown AC; Kieba I; Dhingra A; Boesze-Battaglia K; Lally ET
Cell Microbiol; 2019 Mar; 21(3):e12967. PubMed ID: 30329215
[TBL] [Abstract][Full Text] [Related]
8. Aggregatibacter actinomycetemcomitans LtxC is required for leukotoxin activity and initial interaction between toxin and host cells.
Balashova NV; Shah C; Patel JK; Megalla S; Kachlany SC
Gene; 2009 Aug; 443(1-2):42-7. PubMed ID: 19450669
[TBL] [Abstract][Full Text] [Related]
9.
Vega BA; Belinka BA; Kachlany SC
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31454891
[No Abstract] [Full Text] [Related]
10. Epigallocatechin gallate alters leukotoxin secretion and Aggregatibacter actinomycetemcomitans virulence.
Chang EH; Brown AC
J Pharm Pharmacol; 2021 Mar; 73(4):505-514. PubMed ID: 33793838
[TBL] [Abstract][Full Text] [Related]
11. Aggregatibacter actinomycetemcomitans leukotoxin cytotoxicity occurs through bilayer destabilization.
Brown AC; Boesze-Battaglia K; Du Y; Stefano FP; Kieba IR; Epand RF; Kakalis L; Yeagle PL; Epand RM; Lally ET
Cell Microbiol; 2012 Jun; 14(6):869-81. PubMed ID: 22309134
[TBL] [Abstract][Full Text] [Related]
12. Membrane association and destabilization by Aggregatibacter actinomycetemcomitans leukotoxin requires changes in secondary structures.
Walters MJ; Brown AC; Edrington TC; Baranwal S; Du Y; Lally ET; Boesze-Battaglia K
Mol Oral Microbiol; 2013 Oct; 28(5):342-53. PubMed ID: 23678967
[TBL] [Abstract][Full Text] [Related]
13. Aggregatibacter actinomycetemcomitans leukotoxin (LtxA; Leukothera) induces cofilin dephosphorylation and actin depolymerization during killing of malignant monocytes.
Kaur M; Kachlany SC
Microbiology (Reading); 2014 Nov; 160(Pt 11):2443-2452. PubMed ID: 25169107
[TBL] [Abstract][Full Text] [Related]
14. Aggregatibacter actinomycetemcomitans leukotoxin induces cytosol acidification in LFA-1 expressing immune cells.
Balashova N; Dhingra A; Boesze-Battaglia K; Lally ET
Mol Oral Microbiol; 2016 Feb; 31(1):106-14. PubMed ID: 26361372
[TBL] [Abstract][Full Text] [Related]
15. Toxin-triggered liposomes for the controlled release of antibiotics to treat infections associated with the gram-negative bacterium, Aggregatibacter actinomycetemcomitans.
Li Z; Baidoun R; Brown AC
Colloids Surf B Biointerfaces; 2024 Jun; 238():113870. PubMed ID: 38555763
[TBL] [Abstract][Full Text] [Related]
16. Identification and immunological characterization of the domain of Actinobacillus actinomycetemcomitans leukotoxin that determines its specificity for human target cells.
Lally ET; Golub EE; Kieba IR
J Biol Chem; 1994 Dec; 269(49):31289-95. PubMed ID: 7983074
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane.
Chang EH; Giaquinto P; Huang J; Balashova NV; Brown AC
Mol Oral Microbiol; 2020 Jan; 35(1):29-39. PubMed ID: 31816197
[TBL] [Abstract][Full Text] [Related]
18. Catechin-mediated restructuring of a bacterial toxin inhibits activity.
Chang EH; Huang J; Lin Z; Brown AC
Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):191-198. PubMed ID: 30342156
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron.
Balashova NV; Diaz R; Balashov SV; Crosby JA; Kachlany SC
J Bacteriol; 2006 Dec; 188(24):8658-61. PubMed ID: 17041062
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coli.
Fagerberg SK; Jakobsen MR; Skals M; Praetorius HA
Infect Immun; 2016 Nov; 84(11):3114-3130. PubMed ID: 27528275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
